Korea’s Clinical Trial Landscape In 2022: Approvals Fall To Pre-COVID Levels
MSD, Janssen, Chong Kun Dang, Daewoong Top Sponsors
The Pink Sheet takes an infographic look at South Korea's clinical trial trends in 2022 to illustrate how the country's biopharma R&D is developing and how activities are recovering in the post-pandemic situation. One key takeaway is that approvals for trial starts have fallen back to pre-COVID levels, suggesting a falling off of activity related to drugs and vaccines for the virus.
